Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
16/9 11:12
Over the past few years, Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those losses by quickly developing and marketing COVID-19 diagnostic tests. However, sale...